Mepolizumab in the Treatment of Patients With Severe Uncontrolled CRSwNP: a Multicentric Real Life Observational Study

NCT06258772 · clinicaltrials.gov ↗

UNKNOWN

Status

199

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: Mepolizumab Auto-Injector

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS